>> Continued From the Previous Page <<
But when Medicare steps in? The price soars to an absurd $2,400.
“If every one of those scripts was filled at our pharmacy, instead of through Medicare, it would’ve cost $4 million,” Hart said. “That means that we are $596 million cheaper than the insurance. That’s crazy.”
A report from the National Cancer Institute backs up the significance of this drug, calling it a “landmark” medication that has dramatically improved survival rates for patients with chronic myelogenous leukemia. Given its importance, Medicare covered 250,000 prescriptions of the drug in a single year, leading to a staggering $600 million in costs.
So why is Medicare being charged an astronomical price for a drug that should cost a fraction of that? Hart has an answer.
“Insurance companies pay a middleman, the pharmacy benefits manager, and that person decides how much that medication’s gonna cost,” he explained. These PBMs operate behind the scenes, determining drug prices and reimbursement rates. And because they take a percentage of the final cost—rather than a flat fee—they have every incentive to keep prices high.
Hart isn’t the only one raising alarms over PBMs. A House Oversight Committee report last year found that just three major players—CVS Caremark, Cigna Express Scripts, and UnitedHealth Group’s Optum Rx—control over 80 percent of the market. These companies are deeply intertwined with insurers and healthcare providers, and their influence over drug pricing is undeniable.
The committee’s findings were damning.
“Instead, the opposite has occurred: patients are seeing significantly higher costs with fewer choices and worse care,” the report stated. Lawmakers discovered over 300 cases in which PBMs “preferred medications that cost at least $500 per claim more than the alternative medication they excluded on their formulary.”
Despite the promises that these middlemen negotiate better prices, real-world evidence suggests they are doing just the opposite—driving up costs and limiting patient choices.
KICK OUT The Cold and Say Hello to The Handyheater! Warming Any Spot INSTANTLY!
This revelation is yet another example of how bureaucratic red tape, corporate monopolies, and government mismanagement are pushing America’s healthcare system to the brink. Pharmaceutical companies develop groundbreaking medications, but between federal regulations and corporate greed, those innovations often come at an unbearable cost to the average citizen.
At what point will lawmakers step in and put an end to this blatant abuse of taxpayer money? When will American families stop being the victims of a rigged system that prioritizes profits over people?
If nothing changes, the government will continue pouring billions into a broken system, and everyday Americans will keep paying the price—literally and figuratively. The question is, how much more are we willing to take?
